• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肝素硫酸盐与病毒加工酶弗林结合所需的结构特征。

Structural characteristics of Heparan sulfate required for the binding with the virus processing Enzyme Furin.

机构信息

The First Affiliated Hospital of Guangzhou University of Chinese Medicine, No. 16 Jichang Road, Guangdong Province, 510405, Guangzhou, China.

Carbohydrate-Based Drug Research Center, Shanghai Institute of Materia Medica, Chinese Academy of Sciences, 555 Zuchongzhi Road, Shanghai, 200031, China.

出版信息

Glycoconj J. 2022 Jun;39(3):315-325. doi: 10.1007/s10719-021-10018-8. Epub 2021 Oct 26.

DOI:10.1007/s10719-021-10018-8
PMID:34699015
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8546381/
Abstract

Furin is one of the nine-member proprotein convertase family. Furin cleaves proteins with polybasic residues, which includes many viral glycoproteins such as SARS-Cov-2 spike protein. The cleavage is required for the activation of the proteins. Currently, the mechanisms that regulate Furin activity remain largely unknown. Here we demonstrated that Furin is a novel heparin/heparan sulfate binding protein by the use of biochemical and genetic assays. The K is 9.78 nM based on the biolayer interferometry assay. Moreover, we found that sulfation degree, site-specific sulfation (N-sulfation and 3-O-sulfation), and iduronic acid are the major structural determinants for the binding. Furthermore, we found that heparin inhibits the enzymatic activity of Furin when pre-mixes heparin with either Furin or Furin substrate. We also found that the Furin binds with cells of different origin and the binding with the cells of lung origin is the strongest one. These data could advance our understanding of the working mechanism of Furin and will benefit the Furin based drug discovery such as inhibitors targeting the interaction between heparan sulfate and Furin for inhibition of viral infection.

摘要

弗林是九种蛋白原转化酶家族之一。弗林可切割具有多碱性残基的蛋白质,其中包括许多病毒糖蛋白,如 SARS-CoV-2 刺突蛋白。这种切割对于蛋白质的激活是必需的。目前,调节弗林活性的机制在很大程度上仍不清楚。在这里,我们通过生化和遗传分析证明了弗林是一种新型肝素/硫酸乙酰肝素结合蛋白。根据生物层干涉测定法,K 值为 9.78 nM。此外,我们发现硫酸化程度、位点特异性硫酸化(N-硫酸化和 3-O-硫酸化)和艾杜糖醛酸是结合的主要结构决定因素。此外,我们发现肝素在与弗林或弗林底物预混合时抑制弗林的酶活性。我们还发现弗林与不同来源的细胞结合,与肺源细胞的结合最强。这些数据可以增进我们对弗林作用机制的理解,并有助于基于弗林的药物发现,例如针对肝素硫酸酯和弗林相互作用的抑制剂,以抑制病毒感染。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db1/8546381/b406e06f7f54/10719_2021_10018_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db1/8546381/ad8db90d9945/10719_2021_10018_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db1/8546381/ebe7fabb4d88/10719_2021_10018_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db1/8546381/442402f7e1ad/10719_2021_10018_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db1/8546381/d2f518dacdcd/10719_2021_10018_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db1/8546381/b406e06f7f54/10719_2021_10018_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db1/8546381/ad8db90d9945/10719_2021_10018_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db1/8546381/ebe7fabb4d88/10719_2021_10018_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db1/8546381/442402f7e1ad/10719_2021_10018_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db1/8546381/d2f518dacdcd/10719_2021_10018_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/0db1/8546381/b406e06f7f54/10719_2021_10018_Fig5_HTML.jpg

相似文献

1
Structural characteristics of Heparan sulfate required for the binding with the virus processing Enzyme Furin.肝素硫酸盐与病毒加工酶弗林结合所需的结构特征。
Glycoconj J. 2022 Jun;39(3):315-325. doi: 10.1007/s10719-021-10018-8. Epub 2021 Oct 26.
2
Natural and Recombinant SARS-CoV-2 Isolates Rapidly Evolve to Higher Infectivity through More Efficient Binding to Heparan Sulfate and Reduced S1/S2 Cleavage.天然和重组 SARS-CoV-2 分离株通过更有效地结合硫酸乙酰肝素和减少 S1/S2 裂解而迅速进化为更高的感染力。
J Virol. 2021 Oct 13;95(21):e0135721. doi: 10.1128/JVI.01357-21. Epub 2021 Aug 18.
3
The binding of heparin to spike glycoprotein inhibits SARS-CoV-2 infection by three mechanisms.肝素与刺突糖蛋白结合通过三种机制抑制 SARS-CoV-2 感染。
J Biol Chem. 2022 Feb;298(2):101507. doi: 10.1016/j.jbc.2021.101507. Epub 2021 Dec 18.
4
A Feasible Alternative Strategy Targeting Furin Disrupts SARS-CoV-2 Infection Cycle.针对弗林蛋白酶的可行替代策略可破坏 SARS-CoV-2 感染周期。
Microbiol Spectr. 2022 Feb 23;10(1):e0236421. doi: 10.1128/spectrum.02364-21. Epub 2022 Feb 9.
5
Cleavage of group 1 coronavirus spike proteins: how furin cleavage is traded off against heparan sulfate binding upon cell culture adaptation.第1组冠状病毒刺突蛋白的切割:在细胞培养适应过程中,弗林蛋白酶切割如何与硫酸乙酰肝素结合相互权衡。
J Virol. 2008 Jun;82(12):6078-83. doi: 10.1128/JVI.00074-08. Epub 2008 Apr 9.
6
SARS-CoV-2 Spike Furin Cleavage Site and S2' Basic Residues Modulate the Entry Process in a Host Cell-Dependent Manner.SARS-CoV-2 刺突蛋白的弗林蛋白酶裂解位点和 S2'碱性残基以宿主细胞依赖的方式调节进入过程。
J Virol. 2022 Jul 13;96(13):e0047422. doi: 10.1128/jvi.00474-22. Epub 2022 Jun 9.
7
A novel antibody against the furin cleavage site of SARS-CoV-2 spike protein: Effects on proteolytic cleavage and ACE2 binding.一种针对 SARS-CoV-2 刺突蛋白furin 切割位点的新型抗体:对蛋白水解切割和 ACE2 结合的影响。
Immunol Lett. 2022 Feb;242:1-7. doi: 10.1016/j.imlet.2022.01.002. Epub 2022 Jan 7.
8
ACE2-Independent Interaction of SARS-CoV-2 Spike Protein with Human Epithelial Cells Is Inhibited by Unfractionated Heparin.SARS-CoV-2 刺突蛋白与人类上皮细胞的非依赖性相互作用被未分级肝素抑制。
Cells. 2021 Jun 7;10(6):1419. doi: 10.3390/cells10061419.
9
The furin protease cleavage recognition sequence of Sindbis virus PE2 can mediate virion attachment to cell surface heparan sulfate.辛德毕斯病毒PE2的弗林蛋白酶切割识别序列可介导病毒粒子附着于细胞表面硫酸乙酰肝素。
J Virol. 1999 Aug;73(8):6299-306. doi: 10.1128/JVI.73.8.6299-6306.1999.
10
Distinctive Roles of Furin and TMPRSS2 in SARS-CoV-2 Infectivity.弗林蛋白酶和 TMPRSS2 在 SARS-CoV-2 感染中的独特作用。
J Virol. 2022 Apr 27;96(8):e0012822. doi: 10.1128/jvi.00128-22. Epub 2022 Mar 28.

引用本文的文献

1
Alterations in heparan sulfate proteoglycan synthesis and sulfation and the impact on vascular endothelial function.硫酸乙酰肝素蛋白聚糖合成与硫酸化的改变及其对血管内皮功能的影响。
Matrix Biol Plus. 2022 Sep 7;16:100121. doi: 10.1016/j.mbplus.2022.100121. eCollection 2022 Dec.
2
Is heparan sulfate a target for inhibition of RNA virus infection?硫酸乙酰肝素是否是抑制 RNA 病毒感染的靶点?
Am J Physiol Cell Physiol. 2022 Apr 1;322(4):C605-C613. doi: 10.1152/ajpcell.00028.2022. Epub 2022 Feb 23.
3
Inhaled heparin polysaccharide nanodecoy against SARS-CoV-2 and variants.

本文引用的文献

1
Heparan Sulfate Facilitates Spike Protein-Mediated SARS-CoV-2 Host Cell Invasion and Contributes to Increased Infection of SARS-CoV-2 G614 Mutant and in Lung Cancer.硫酸乙酰肝素促进刺突蛋白介导的SARS-CoV-2宿主细胞侵袭,并导致SARS-CoV-2 G614突变体在肺癌中的感染增加。
Front Mol Biosci. 2021 Jun 11;8:649575. doi: 10.3389/fmolb.2021.649575. eCollection 2021.
2
The Impact of Anticoagulation on COVID-19 (SARS CoV-2) Patient Outcomes: A Systematic Review.抗凝治疗对 COVID-19(SARS-CoV-2)患者结局的影响:一项系统评价。
J Pharm Pract. 2022 Dec;35(6):1000-1006. doi: 10.1177/08971900211015055. Epub 2021 May 7.
3
吸入式抗SARS-CoV-2及其变体的肝素多糖纳米诱饵
Acta Pharm Sin B. 2022 Jul;12(7):3187-3194. doi: 10.1016/j.apsb.2022.01.019. Epub 2022 Feb 11.
Platelet Activation and Plasma Levels of Furin Are Associated With Prognosis of Patients With Coronary Artery Disease and COVID-19.
血小板活化和弗林蛋白酶的血浆水平与冠心病和 COVID-19 患者的预后相关。
Arterioscler Thromb Vasc Biol. 2021 Jun;41(6):2080-2096. doi: 10.1161/ATVBAHA.120.315698. Epub 2021 Apr 29.
4
Furin cleavage of SARS-CoV-2 Spike promotes but is not essential for infection and cell-cell fusion.弗林蛋白酶切割 SARS-CoV-2 刺突促进但不是感染和细胞-细胞融合所必需的。
PLoS Pathog. 2021 Jan 25;17(1):e1009246. doi: 10.1371/journal.ppat.1009246. eCollection 2021 Jan.
5
Heparin Inhibits Cellular Invasion by SARS-CoV-2: Structural Dependence of the Interaction of the Spike S1 Receptor-Binding Domain with Heparin.肝素抑制 SARS-CoV-2 的细胞侵袭:刺突 S1 受体结合域与肝素相互作用的结构依赖性。
Thromb Haemost. 2020 Dec;120(12):1700-1715. doi: 10.1055/s-0040-1721319. Epub 2020 Dec 23.
6
Effective Inhibition of SARS-CoV-2 Entry by Heparin and Enoxaparin Derivatives.肝素和依诺肝素衍生物对严重急性呼吸综合征冠状病毒2(SARS-CoV-2)进入的有效抑制作用
J Virol. 2021 Jan 13;95(3). doi: 10.1128/JVI.01987-20.
7
Unfractionated heparin inhibits live wild type SARS-CoV-2 cell infectivity at therapeutically relevant concentrations.未分级肝素在治疗相关浓度下抑制活野生型 SARS-CoV-2 细胞感染性。
Br J Pharmacol. 2021 Feb;178(3):626-635. doi: 10.1111/bph.15304. Epub 2020 Dec 14.
8
SARS-CoV-2 Infection Depends on Cellular Heparan Sulfate and ACE2.SARS-CoV-2 感染依赖于细胞表面的肝素硫酸和 ACE2。
Cell. 2020 Nov 12;183(4):1043-1057.e15. doi: 10.1016/j.cell.2020.09.033. Epub 2020 Sep 14.
9
Sulfated polysaccharides effectively inhibit SARS-CoV-2 in vitro.硫酸化多糖在体外能有效抑制新型冠状病毒。
Cell Discov. 2020 Jul 24;6(1):50. doi: 10.1038/s41421-020-00192-8. eCollection 2020.
10
Characterization of heparin and severe acute respiratory syndrome-related coronavirus 2 (SARS-CoV-2) spike glycoprotein binding interactions.肝素与严重急性呼吸综合征相关冠状病毒 2(SARS-CoV-2)刺突糖蛋白结合相互作用的表征。
Antiviral Res. 2020 Sep;181:104873. doi: 10.1016/j.antiviral.2020.104873. Epub 2020 Jul 10.